ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 153 filers reported holding ITEOS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $114 | -19.1% | 10,381 | -2.4% | 0.01% | -38.9% |
Q2 2023 | $141 | -12.4% | 10,641 | -10.2% | 0.02% | +20.0% |
Q1 2023 | $161 | -100.0% | 11,856 | -29.8% | 0.02% | -61.5% |
Q2 2022 | $348,000 | -36.7% | 16,900 | -1.2% | 0.04% | -40.0% |
Q1 2022 | $550,000 | – | 17,100 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 3,706,663 | $126,694,000 | 24.48% |
MPM BioImpact LLC | 2,355,557 | $80,513,000 | 10.12% |
Boxer Capital, LLC | 4,345,016 | $148,513,000 | 5.04% |
RA Capital Management | 4,417,258 | $150,982,000 | 2.28% |
Ally Bridge Group (NY) LLC | 322,794 | $11,033,000 | 2.12% |
Asymmetry Capital Management, L.P. | 102,286 | $3,496,000 | 1.81% |
RTW INVESTMENTS, LP | 2,762,791 | $94,432,000 | 1.47% |
COWEN AND COMPANY, LLC | 588,238 | $20,106,000 | 1.38% |
Artal Group S.A. | 1,094,047 | $37,395,000 | 0.66% |
HighVista Strategies LLC | 19,804 | $677,000 | 0.50% |